MHRA одобряет вакцину Moderna против мРНК COVID-19

Medicines and Healthcare products Regulatory Agency (MHRA), the regulator of all medicines and medical devices in the UK has approved Moderna-х COVID-19 vaccine after meeting the required safety, quality and effectiveness standards for use in the UK ⁽¹⁾.  

This is the third COVID-19 vaccine to be approved in the UK after Pfizer/BioNTech’s мРНК vaccine BNT162b2 and Oxford/AstraZeneca’s ChAdOx1 nCoV-2019.  

Как и BNT162b2 Pfizer / BioNTech, этот вакцина а также мРНК вакцина and works on the same principle of injecting viral мРНК in to the cells ⁽²⁾.  

источники:  

1. MHRA 2021. Press release – современный vaccine becomes third COVID-19 vaccine approved by UK regulator. Published 8 January 2021. Available on https://www.gov.uk/government/news/moderna-vaccine-becomes-third-covid-19-vaccine-approved-by-uk-regulator Доступ 08 января 2021 г.  

2. Prasad U., 2020. COVID-19 мРНК Vaccine: A Milestone in Science and a Game Changer in Medicine. Scientific European. Posted online on 29 December 2020. Available online on https://www.scientificeuropean.co.uk/medicine/covid-19-mrna-vaccine-a-milestone-in-science-and-a-game-changer-in-medicine/ Доступ 08 января 2021 г.